CDC, FDA lift pause on using J&J's coronavirus vaccine, add safety warning

The US Centers for Disease Control and Prevention and Food and Drug Administration lifted their recommended pause on use of Johnson & Johnson's coronavirus vaccine Friday and said the label will be updated to warn of blood clot risks.

Vaccinations could resume as soon as Saturday, the FDA said.
The agencies acted quickly after a vote by the CDC's Advisory Committee for Immunization Practices recommended lifting the pause.
"We have concluded that the known and potential benefits of the Janssen COVID-19 vaccine outweigh its known and potential risks in individuals 18 years of age and older," acting FDA Commissioner Dr. Janet Woodcock said in a statement.